194 related articles for article (PubMed ID: 15992531)
1. Activated protein C resistance due to factor V Leiden, elevated coagulation factor VIII and postoperative deep vein thrombosis in late breast reconstruction with a free TRAM flap: a report of two cases.
Olsson E; Höijer P
Br J Plast Surg; 2005 Jul; 58(5):720-3. PubMed ID: 15992531
[TBL] [Abstract][Full Text] [Related]
2. Factor V Leiden mutation and thrombotic occlusion of microsurgical anastomosis after free TRAM flap.
Handschin AE; Guggenheim M; Calcagni M; Künzi W; Giovanoli P
Clin Appl Thromb Hemost; 2010 Apr; 16(2):199-203. PubMed ID: 19022796
[TBL] [Abstract][Full Text] [Related]
3. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden.
Graf LL; Welsh CH; Qamar Z; Marlar RA
Am J Clin Pathol; 2003 Jan; 119(1):52-60. PubMed ID: 12520697
[TBL] [Abstract][Full Text] [Related]
4. Elevated coagulation factor VIII, postoperative thrombosis and flap failure in late breast reconstruction with a free TRAM flap: a case report.
Höijer P; Olsson E
J Plast Reconstr Aesthet Surg; 2006; 59(1):102-4. PubMed ID: 16482798
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden associated with flap loss in microsurgical breast reconstruction.
Khansa I; Colakoglu S; Tomich DC; Nguyen MD; Lee BT
Microsurgery; 2011 Jul; 31(5):409-12. PubMed ID: 21503971
[TBL] [Abstract][Full Text] [Related]
6. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
7. Recurrent deep-vein thrombosis based on homozygous factor V Leiden mutation acquired after liver transplantation.
Willems M; Sterneck M; Langer F; Jung R; Haddad M; Hagel C; Kuetemeier R; Eifrig B; Broering D; Fischer L; Rogiers X
Liver Transpl; 2003 Aug; 9(8):870-3. PubMed ID: 12884202
[TBL] [Abstract][Full Text] [Related]
8. [Oral contraceptives and activated protein C resistance: a paradigmatic example of genotype and environment interaction in the development of deep venous thrombosis].
Panzini E; Raffa S; Miconi R; Lozzi A; Marci M
Clin Ter; 1999; 150(6):445-7. PubMed ID: 10756665
[TBL] [Abstract][Full Text] [Related]
9. Venous thrombosis after microvascular free-tissue transfer in head and neck cancer reconstruction.
Fukuiwa T; Nishimoto K; Hayashi T; Kurono Y
Auris Nasus Larynx; 2008 Sep; 35(3):390-6. PubMed ID: 18242027
[TBL] [Abstract][Full Text] [Related]
10. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
11. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of factor V Leiden in the Chinese population.
Ho CH; Chau WK; Hsu HC; Gau JP; Chih CM
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Dec; 62(12):875-8. PubMed ID: 10634001
[TBL] [Abstract][Full Text] [Related]
13. Congenital and acquired activated protein C resistance.
Nicolaes GA; Dahlbäck B
Semin Vasc Med; 2003 Feb; 3(1):33-46. PubMed ID: 15199491
[TBL] [Abstract][Full Text] [Related]
14. Intraindividual consistency of the activated protein C resistance phenotype.
Tosetto A; Simioni M; Madeo D; Rodeghiero F
Br J Haematol; 2004 Aug; 126(3):405-9. PubMed ID: 15257714
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
Middendorf K; Göhring P; Huehns TY; Seidel D; Steinbeck G; Nikol S
Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C resistance test using factor VIII-deficient plasma: a new approach to the venous thrombotic risk?
André E; Hacquard M; Alnot Y; de Maistre E; Lecompte T
Thromb Haemost; 2007 Sep; 98(3):693-4. PubMed ID: 17849066
[No Abstract] [Full Text] [Related]
17. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden with deep venous thrombosis.
Gardner J
Clin Lab Sci; 2003; 16(1):6-9. PubMed ID: 12587652
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
20. [Activated protein C resistance of an acquired nature: the potential role of hormonal treatment and of elevated factor VIII plasma levels].
Iturbe Hernández T; Varo MJ; Olave MT; Fuertes MA; Cornudella R
Rev Clin Esp; 1999 Sep; 199(9):618. PubMed ID: 10568160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
